Asia
18 August 2025 Insulet and Masimo are among the parties that feature in this year’s one-of-a-kind rankings, courtesy of sister magazine WIPR, detailing the year’s most significant trade secrets matters around the world and who handled them.
21 November 2024
3 October 2023
21 July 2022
Latest Features
Asia
Hui Zhuang of CCPIT Patent and Trademark Law Office discusses several strategies to increase the chance of pharmaceutical or food trademarks that include ingredients being registered.
Biotechnology
Agreeing to a dispute resolution mechanism in an international joint venture requires forward thinking, say Jens Petry and Tom Gassmann, Squire Patton Boggs.
Asia
Five cases in which preliminary injunctions were granted are examined by Takanori Abe of Abe & Partners.
Asia
A Korean district court has applied a landmark ruling in a complicated vaccine dispute involving Pfizer, explain Young Kim, Yu-Seog WON, In Hwan Kim, and Amy Oh of Kim & Chang.
Asia
Amid worldwide interest, India could position itself as a global hub for a desperately needed technology, say Kavita Arora and Shaivya Dhawan of K&S Partners.
Asia
The Tokyo District Court judgment on patent infringement and question of territoriality is game-changing, says Takanori Abe of Abe & Partners.
Africa
The global pandemic has increased collaboration and a new wave of disputes is likely. Arbitration is well placed to help, argue Kate Davies McGill, Gaela Gehring Flores and Paul Keller of Allen & Overy
Asia
Recent changes to patent law in China sees registration, review and litigation fall in line with established international IP systems, say Venable partners Keith Haddaway and Christopher Loh.
More News
9 May 2022 Illumina has been ordered to pay more than $333 million to Chinese sequencing company MGI—a subsidiary of BGI Group formally known as Complete Genomics—following a jury ruling that Illumina infringed two of its DNA-sequencing patents.
22 February 2022 Johnson & Johnson unit Janssen Pharmaceuticals has filed a suit against Intas Pharmaceuticals, seeking to block the India-based drugmaker from launching a generic version of schizophrenia drug Invega Sustenna (paliperidone palmitate).
9 November 2021 The China National Intellectual Property Administration has accepted its first set of drug patent linkage complaints since the introduction of a new patent law in June 2021.
21 October 2021 Pfizer is seeking to block a generic version of its cancer drug Ibrance from entering the market until the patent covering the drug expires in May 2036.
20 August 2021 The World Health Organization has identified counterfeit versions of the Covishield vaccine in India and Uganda.
26 January 2021 A US federal court has upheld a preliminary injunction against a Chinese doctor accused of stealing trade secrets from US heart device manufacturer AtriCure.
25 January 2021 Representatives of South Africa and India have again tried and failed to persuade the World Trade Organization to waive IP rights related to COVID-19 treatments and vaccinations.
Get up-to-date information on all our publications and events
Get critical life sciences news direct to your inbox